Manipal Hospitals
| India | Turkey | Austria | |
| Removal of rhabdomyosarcoma | from $4,500 | from $15,000 | from $30,000 |
| Radiation therapy for colorectal cancer | from $3,200 | from $7,000 | from $12,000 |
| Radiation Therapy for Sarcomas | from $4,500 | from $3,250 | from $18,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
| Complex treatment of rhabdomyosarcoma | from $25,000 | from $45,000 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Rhabdomyosarcoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Rhabdomyosarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Rhabdomyosarcoma treatment journey.
A leading pediatric hematologist-oncologist specializing in complex childhood cancers like Rhabdomyosarcoma.
The doctor received Surgical Oncology training at Tata Memorial Hospital, Mumbai, and completed MRCS at the Royal College of Surgeons, Edinburgh. Starting practice in 2000, the doctor founded Curie Manavata Cancer Centre in 2007. With 19 years of experience, the doctor has performed over 50,000 cancer surgeries and participated in more than 200 clinical trials. The doctor is a published author with numerous international and national publications. Specializing in Breast and Thoracic Surgical Oncology, the doctor is a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at MUHS.
The doctor is a highly skilled surgical oncologist with extensive experience in performing over 15,000 cancer surgeries across a range of complexities. This impressive volume of surgeries highlights a profound expertise in the field of oncology, underscoring a commitment to advancing surgical techniques and improving patient outcomes.
Treating rhabdomyosarcoma in India involves a multidisciplinary team led by pediatric or medical oncologists. These experts coordinate chemotherapy protocols at NABH-accredited facilities. Specialized surgeons, radiation oncologists, and pathologists collaborate within tumor boards. This ensures precise staging and local control for various tumor locations.
Bookimed Expert Insight: Manipal Hospitals and Global Hospital Chennai manage over 80,000 patients annually. Our data shows these large tertiary centers offer integrated teams under one roof. This is vital because rhabdomyosarcoma requires immediate coordination between pathology and surgery. Choosing a multi-specialty group prevents delays in starting risk-adapted treatment protocols.
Patient Consensus: Patients note that a tumor board approach is the standard for managing this complex cancer. They emphasize that while one doctor often starts the process, a full team handles the treatment.
Indian hospitals offer multimodal rhabdomyosarcoma treatment including risk-adapted chemotherapy, surgery, and advanced radiation. Facilities like Manipal Hospitals and Fortis Gurgaon use international protocols from the Childrens Oncology Group. This approach ensures high standards for pediatric oncology care and localized tumor control.
Bookimed Expert Insight: Patient volume is a major indicator of expertise in India. Global Hospital Chennai and Manipal Hospitals each serve 2,000,000 patients annually. This massive scale allows oncologists to manage rare cases like rhabdomyosarcoma more frequently than smaller centers. When choosing a facility, look for those with dedicated pediatric departments like Fortis Gurgaon, which is recognized globally for its technical advancement.
Patient Consensus: Patients note it is vital to seek care at specialized sarcoma centers rather than general hospitals. They emphasize that treatment plans are highly individualized based on the tumor's specific location and response to initial chemotherapy.
Top Indian hospitals for rhabdomyosarcoma treatment are located in Bengaluru, Gurgaon, Chennai, and Mumbai. These major medical hubs host facilities with NABH and JCI accreditations. Specialized centers feature dedicated pediatric oncology units equipped for complex chemotherapy and advanced radiation protocols.
Bookimed Expert Insight: While Mumbai and Delhi are traditional hubs, Bengaluru and Chennai have emerged as high-capacity alternatives. Clinics like Manipal Hospitals and Global Hospital Chennai manage over 2,000,000 patients every year. These facilities often provide greater bed availability for long-term childhood cancer treatments compared to overcrowded government centers.
Patient Consensus: Patients emphasize choosing dedicated pediatric programs over general hospitals for rare sarcomas. Many note it is vital to secure second pathology opinions before starting intensive chemotherapy or radiation.
India offers advanced rhabdomyosarcoma therapies including proton beam therapy and molecularly targeted treatments. Major oncology centers provide intensity-modulated radiation therapy to protect vital organs. Leading institutes also integrate immunotherapy and genetic profiling to tailor specific protocols for complex or relapsed pediatric cases.
Bookimed Expert Insight: Clinical volume serves as a critical quality indicator in India. Facilities like Manipal Hospitals and Global Hospital Chennai serve 2 million patients annually. This massive scale allows these institutions to maintain dedicated sarkoma units. These units often provide access to clinical trials for high-risk subtypes like alveolar rhabdomyosarcoma.
Patient Consensus: Patients emphasize starting standard treatment quickly rather than delaying care to search for experimental options. Many recommend getting a second opinion to confirm the pathology subtype before beginning advanced radiation.